Cargando…
HES5 silencing is an early and recurrent change in prostate tumourigenesis
Prostate cancer is the most common cancer in men, resulting in over 10 000 deaths/year in the UK. Sequencing and copy number analysis of primary tumours has revealed heterogeneity within tumours and an absence of recurrent founder mutations, consistent with non-genetic disease initiating events. Usi...
Autores principales: | Massie, Charles E, Spiteri, Inmaculada, Ross-Adams, Helen, Luxton, Hayley, Kay, Jonathan, Whitaker, Hayley C, Dunning, Mark J, Lamb, Alastair D, Ramos-Montoya, Antonio, Brewer, Daniel S, Cooper, Colin S, Eeles, Rosalind, Warren, Anne Y, Tavaré, Simon, Neal, David E, Lynch, Andy G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335379/ https://www.ncbi.nlm.nih.gov/pubmed/25560400 http://dx.doi.org/10.1530/ERC-14-0454 |
Ejemplares similares
-
The Early Effects of Rapid Androgen Deprivation on Human Prostate Cancer
por: Shaw, Greg L., et al.
Publicado: (2016) -
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
por: Buhigas, Claudia, et al.
Publicado: (2022) -
Regulation of the localisation and function of the oncogene LYRIC/AEG‐1 by ubiquitination at K486 and K491
por: Luxton, Hayley J., et al.
Publicado: (2014) -
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer
por: Pertega-Gomes, Nelma, et al.
Publicado: (2015) -
HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network
por: Ramos-Montoya, Antonio, et al.
Publicado: (2014)